Metastatic Sinonasal Adenocarcinoma
1 clinical trials · Condition
◉ Watch Metastatic Sinonasal Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors (NCT06176989) | National Cancer Institute (NCI) | 2024-03-04 |
Track Metastatic Sinonasal Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.